Abstract
ObjectiveTo evaluate the efficiency of resources allocation and sustainability of the use of netupitant+palonosetron (NEPA) for chemotherapy-induced nausea and vomiting (CINV) prophylaxis assuming the Italian National Health Service (NHS) perspective....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have